ACAM2000 is a smallpox vaccine manufactured by Sanofi Pasteur Biologics Co. It provides protection against smallpox for people determined to be at high...
8 KB (815 words) - 22:09, 16 August 2024
Vero cells to develop ACAM2000, which entered mass production at Baxter. The United States ordered over 200 million doses of ACAM2000 in 1999–2001 for its...
112 KB (12,177 words) - 20:51, 15 August 2024
with ACAM2000 is 5.7 per 1,000 of primary vaccinees. On September 1, 2007, the U.S. Food and Drug Administration (FDA) licensed a new vaccine ACAM2000 against...
32 KB (3,482 words) - 21:20, 18 August 2024
a smallpox vaccination in comparison with a COVID-19 vaccination. The ACAM2000 smallpox vaccine has been known to cause myopericarditis in some people...
6 KB (576 words) - 10:12, 3 December 2023
be administered intravenously, and may cause serious kidney toxicity. ACAM2000 is a smallpox vaccine developed by Acambis. It was approved for use in...
164 KB (17,778 words) - 18:14, 22 August 2024
the State Research Center of Virology and Biotechnology VECTOR in Russia ACAM2000, manufactured by Emergent Bio Solutions. Available (but not used) for use...
29 KB (4,154 words) - 08:56, 19 August 2024
the State Research Center of Virology and Biotechnology VECTOR in Russia ACAM2000, manufactured by Emergent Bio Solutions. Available (but not used) for use...
76 KB (6,770 words) - 04:16, 25 August 2024
vaccination with ACAM2000 is "administered as one percutaneous dose via multiple puncture technique with a bifurcated needle". However, ACAM2000 is not recommended...
181 KB (19,696 words) - 16:31, 25 August 2024
Stockpile (SNS) holds over 100 million doses of an older smallpox vaccine (ACAM2000). As of June 28, the Biden administration was allocating tens of thousands...
84 KB (5,253 words) - 14:30, 22 August 2024
History Previous outbreaks Timeline 2023–2024 mpox epidemic By location Vaccines Smallpox vaccine MVA-BN (Imvanex/Jynneos) ACAM2000 Category Task Force...
19 KB (1,344 words) - 01:14, 18 August 2024
History Previous outbreaks Timeline 2023–2024 mpox epidemic By location Vaccines Smallpox vaccine MVA-BN (Imvanex/Jynneos) ACAM2000 Category Task Force...
7 KB (851 words) - 15:41, 21 May 2024
History Previous outbreaks Timeline 2023–2024 mpox epidemic By location Vaccines Smallpox vaccine MVA-BN (Imvanex/Jynneos) ACAM2000 Category Task Force...
49 KB (3,625 words) - 02:08, 27 July 2024
casein, dextrose, galactose, lactose, sucrose, yeast extract Vaccinia (ACAM2000) Glycerin, human serum albumin, mannitol, neomycin, phenol, polymyxin B...
14 KB (178 words) - 09:40, 20 August 2024
History Previous outbreaks Timeline 2023–2024 mpox epidemic By location Vaccines Smallpox vaccine MVA-BN (Imvanex/Jynneos) ACAM2000 Category Task Force...
10 KB (1,076 words) - 15:39, 21 May 2024
approved in 2007, against measles developed using a primary cell line. ACAM2000 is a smallpox vaccine approved by the Food and Drug Administration in 2007...
16 KB (1,533 words) - 02:48, 30 January 2023
Emergent in arbitration proceedings. In 2017, the company purchased the ACAM2000 (smallpox vaccinia) Vaccine, the only FDA-approved (2007)vaccine for active...
66 KB (6,852 words) - 21:21, 28 July 2024
Varilrix, Varivax, Zostavax Smallpox vaccine Variola virus DNA Smallpox ACAM2000, Dryvax, Imvanex, Jynneos Yellow fever vaccine Yellow fever virus RNA Yellow...
34 KB (2,305 words) - 03:06, 24 December 2023
resulting from continued vaccinia virus replication after vaccination using ACAM2000 or APSV. VIGIV is not commercially available but can be made available...
16 KB (1,632 words) - 17:31, 27 April 2024
Archived from the original on 26 November 2020. Retrieved 27 December 2020. "ACAM2000 Product Insert". US Food & Drug Administration. Emergent Product Development...
28 KB (2,916 words) - 18:55, 23 April 2024